Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/14/2003WO2002096374A3 Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
08/14/2003WO2002095361A3 Identification of anti-protozoal agents
08/14/2003WO2002081430A3 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
08/14/2003WO2002070653A3 Peptide deformylase inhibitors
08/14/2003WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers
08/14/2003WO2002058733B1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
08/14/2003WO2002058703A3 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
08/14/2003WO2002058626A3 Methods and compositions for the identification and treatment of neurodegenerative disorders
08/14/2003WO2002051439A3 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
08/14/2003WO2002051438A3 Use of repulsive guidance molecule (rgm) and its modulators
08/14/2003WO2002048154A9 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
08/14/2003WO2002046415A3 Polynucleotide and polypeptide sequences of putative transporters and ion channells
08/14/2003WO2002043807A3 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction
08/14/2003WO2002043714A3 Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
08/14/2003WO2002041840A3 Sildenafil citrate chewing gum formulations and methods of using the same
08/14/2003WO2002038142A3 Serotonergic compositions and methods for treatment of mild cognitive impairment
08/14/2003WO2002020475A3 Inhibitors of serine protease activity of matriptase or mtsp1
08/14/2003WO2002015933A3 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
08/14/2003WO2002013866A9 Stimulating neutrophil function to treat inflammatory bowel disease
08/14/2003WO2002011714A3 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
08/14/2003WO2001090421A3 Method of detecting inflammatory lung disorders
08/14/2003US20030153849 Method and apparatus for connective tissue treatment
08/14/2003US20030153808 Implantation rate using ff-mas
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153774 Process for the preparation of citalopram
08/14/2003US20030153766 Dissolving Lansoprazole hydrate in an organic solvent solution or suspension and crystalling and separating a Lansoprazole enantiomorph; resolution; purification; antiulcer agents
08/14/2003US20030153759 1-Glyoxlylamide indolizines for treating cancer
08/14/2003US20030153757 Synthesis and purification of valacyclovir
08/14/2003US20030153756 Pyrimido[5,4-e] [1,2,4]triazine-5, 7-diamine compounds as protein tyrosine phosphatase inhibitors
08/14/2003US20030153755 Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases
08/14/2003US20030153750 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/14/2003US20030153747 Depletion of 7-aminodesacetoxy-cephalosporonic acid in a mixture with 7-amino-3-vinyl-cephalosporonic acid
08/14/2003US20030153744 Such as 4-amino-7-(2'deoxy,-beta-l-erythro-pento-furanosyl) pyrrolo(2,3-D)pyrimidine for treatment of hepatitis B virus infection with reduced side effects
08/14/2003US20030153629 Suppressing biosynthesis of exotoxins using terpenes selected from terpineol, beta-ionone, terpin, linalool, geraniol or menthol, and etherified polyoxyalkylene glycols
08/14/2003US20030153628 Aldose reductase inhibitors and pharmaceutical compositions
08/14/2003US20030153627 Compounds for blocking androgen receptors
08/14/2003US20030153626 Administering antiestrogens, adenosine receptor and calmodulin antagonists for prophylaxis of vision defects
08/14/2003US20030153625 Suppressing bone disordes such as decalcification or fractures in humans having prostate gland cancers by administering antiestrogen selected from triphenylethylene or toremifene; hormone inhibitors
08/14/2003US20030153624 Racemic mixtures of N-(prop-2-ynyl)-2-aminophenylpropane, used for the prophylaxis of neurodegenerative disorders and as immunomodulators
08/14/2003US20030153623 Solid preparation containing sparingly soluble NSAIDs
08/14/2003US20030153622 Ophthalmic solution and contact lens solution
08/14/2003US20030153621 Administering mixtures of 13-hydroxyoctadeca-9Z,11E-dienoic acid (13-HODE) and carriers comprising glycerides or fatty esters as controllers of endothelial growth factors
08/14/2003US20030153620 Administering cetyl myristate and/or cetyl plamitate mixtures for prophylaxis of skin disorders
08/14/2003US20030153618 Treatment and prevention of herpes simplex infections
08/14/2003US20030153617 Anticholesterol agent tablets having a pH within the range of 5.0 to 7.5, based on a 20 wt % aqueous slurry; storage stability
08/14/2003US20030153615 Novel compositions and uses of dictyostatin compounds
08/14/2003US20030153614 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
08/14/2003US20030153613 Hypotensive agents for eye, using an aclurea indole compounds, potassium channel blockers; glaucoma
08/14/2003US20030153612 Method of treatment or prophylaxis of restless legs syndrome with ropinirole compound
08/14/2003US20030153610 Substituted oxazolidinones and their in the field of blood coagulation
08/14/2003US20030153609 C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
08/14/2003US20030153607 Novel composition and use
08/14/2003US20030153606 Antiproliferative agents for treating adipocyte differentiation, cancer, osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease
08/14/2003US20030153605 Enzyme inhibitors of nitric oxide synthase
08/14/2003US20030153604 Anticoagulants
08/14/2003US20030153603 Agent for enhancing accumulation of drugs in tumor tissues
08/14/2003US20030153602 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/14/2003US20030153601 A polyhydroxy-polymethyl-8-tridecenoic acid 8-lactone compounds, as antitumor agents, anticarcinogenic agents
08/14/2003US20030153600 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis
08/14/2003US20030153598 Methods for treating Parkinson's disease with cholinesterase inhibitors
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153595 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
08/14/2003US20030153594 Use of particular compounds for prophylaxis and treatment of hepatitis c
08/14/2003US20030153593 Use of CCI-779 as an antineoplastic agent
08/14/2003US20030153592 Method
08/14/2003US20030153590 Method of treating alcoholism or alcohol abuse
08/14/2003US20030153589 Non-sedating barbiturate compounds as neuroprotective agents
08/14/2003US20030153588 Such as N-butyl-2-(4-(4-chloro-3-methoxyphenyl)-5-pyridin-4-yl-1H-imidazole-2 -yl)isobutylamide for treatment of neurotraumatic disorders
08/14/2003US20030153587 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
08/14/2003US20030153585 Comprises low water soluble 4-(4-(3-chloro-4-methoxybenzyl-amino)-benzo(4,5)thieno(2,3-d)pyrimidin-2 -yllcyclohexane-carboxylic acid; improved oral administration, bioavailability
08/14/2003US20030153583 Solid-state forms of N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazole
08/14/2003US20030153582 Method and composition for treatment of irritable bowel disease
08/14/2003US20030153581 Stabilized difloxacin injectable solution
08/14/2003US20030153580 Cis-imidazolines
08/14/2003US20030153579 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
08/14/2003US20030153578 CCR-3 receptor antagonists (I)
08/14/2003US20030153576 Such as amino-indazoles for treatment of central nervous system disorders
08/14/2003US20030153575 Tetracyclic diketopiperazine compounds as pdev inhibitors
08/14/2003US20030153574 Such as 4-(Benzoxazol-2-yl)-1,4-diazabicyclo(3.2.2)nonane hydrobromide which stimulates nicotinic receptors
08/14/2003US20030153573 Novel N-substituted 4-((-4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties
08/14/2003US20030153572 Compounds and methods for the treatment of pain
08/14/2003US20030153571 Such as 7-Chloro-4-hydroxy-2-(3-pyridyleth-1-yl)-1,2,5,10-tetrahydropyridazino(4,5, -b)quinoline-1,10-dione methanesulfonate, which binds NMDA receptors (N-methyl-aspartic acid receptors); neuropathy
08/14/2003US20030153569 Novel pyrazole and pyrazoline substituted compounds
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153566 Adenosine receptor agonist
08/14/2003US20030153564 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
08/14/2003US20030153563 CRF receptor antagonists and methods relating thereto
08/14/2003US20030153561 Pyrroloquinolones as antiviral agents
08/14/2003US20030153559 Treatment of an oxygen and/or energy deficit; a poly(adenosine diphosphate ribose)-polymerase inhibitor; treating autoimmune, neurodegenerative and diseases caused by a toxic effect; viricides
08/14/2003US20030153558 Immunomodulators and/or inhibiting cytokine release
08/14/2003US20030153557 Treating osteoporosis, cardiovascular disorders, restenosis, arteriosclerosis, nephropathies or retinopathies; antitumor and antiinflammatory agents
08/14/2003US20030153554 Short-acting sedative hypnotic agents for anesthesia and sedation
08/14/2003US20030153553 Quinoline derivatives
08/14/2003US20030153552 Method of treating chemical dependency in mammals and a composition therefor
08/14/2003US20030153551 Staurosporine derivatives; angiogenisis inhibitors
08/14/2003US20030153550 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
08/14/2003US20030153549 Clavulinic acid derivatives; antibiotics
08/14/2003US20030153548 Benzofuran and benzopyran derivatives, aminoalkoxybiphenyl carboxamide compounds and aminoetherbiphenyl compounds
08/14/2003US20030153544 Fatty acid derivatives
08/14/2003US20030153542 Novel anti-inflammatory androstane derivative compositions
1 ... 5375 5376 5377 5378 5379 5380 5381 5382 5383 5384 5385 5386 5387 5388 5389 5390 5391 5392 5393 5394 5395 ... 7860